AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#100135, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

Grant

Awarded By

Total Award Amount

  • 49000.00

    • Direct Costs

  • 38890.00

    • Sponsor Award Id

    • Contributor

  • ponca   Investigator  
  • sbhatia   Investigator  
  • veggie   Investigator  
  • wolfsonj   Investigator  
  • mkutny   Principal Investigator  
  • Aman Wadhwa   Investigator  
  • Ana Xavier   Investigator  
  • Elizabeth Alva   Investigator  
  • Gregory Friedman M.D.   Investigator  
  • Hilary Haines   Investigator  
  • Jamie Aye   Investigator  
  • Jeffrey Lebensburger   Investigator  
  • Joseph Chewning III M.D.   Investigator  
  • Kimberly Whelan M.D.   Investigator